Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC)
Closed
Phase 2
This trial is looking at adding pembrolizumab to chemotherapy and radiotherapy for non small cell lung cancer that can’t be removed by surgery.
It is open to people who haven’t yet had treatment for their lung cancer.
Recruitment start: 13 December 2018
Recruitment end: 30 June 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Petra Jankowska
Merck Sharp & Dohme Ltd
Last reviewed: 20 November 2020
CRUK internal database number: 16684
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
